Target intelligence / Profile preview

DNA polymerase and RNA polymerase (No universal single abbreviation; commonly as "DNAP" (for DNA polymerase) and "RNAP" (for RNA polymerase) in the literature.)

Target
No universal single abbreviation; commonly as "DNAP" (for DNA polymerase) and "RNAP" (for RNA polymerase) in the literature.
Molecular classification
Enzyme, DNA-dependent DNA polymerase: Family A, B, C, D, X, Y (for DNA polymerases), DNA-dependent RNA polymerase: Multi-subunit, crab-claw enzyme complex (for RNA polymerases), Nucleotidyltransferase, Catalytic protein complex
01

Overview

DNA polymerases are essential enzymes that synthesize new DNA strands using existing DNA as templates during replication and repair, acting in processes vital for genome maintenance, fidelity, and transmission. RNA polymerases are large multi-subunit enzyme complexes that transcribe DNA into RNA, a central step in gene expression. Both polymerases are classified as nucleotidyltransferases but differ in substrate specificity, cofactor requirements, and biological context. DNA polymerases require primers and catalyze DNA synthesis, while RNA polymerases initiate RNA chains without primers and perform unwinding of DNA during transcription. Both families are of major biomedical importance, as they are critical to cell proliferation, genomic integrity, and are prime therapeutic targets in cancer, infectious diseases, and genetic disorders. Targeting these enzymes underlies the mechanism of a broad spectrum of drugs including antivirals, antibiotics, and anticancer agents.

Other names
DNA-directed DNA polymeraseDNA replicaseRNA-directed RNA polymerase (for viral variants)DNA-directed RNA polymeraseTranscriptaseDNA pol (for DNA polymerase)RNA pol (for RNA polymerase)Human subtypes: POLA1 (DNA polymerase alpha), POLB, etc.; POLR2A (RNA polymerase II catalytic subunit), and others
02

Mechanism of action

Inhibition of nucleotide incorporation (competitive analogs) Chain termination (nucleoside/nucleotide analogs prevent elongation) Enzyme active site binding/blocking Conformational change or subunit dissociation inhibition

03

Biological functions

DNA replication (by DNA polymerase)Transcription (by RNA polymerase)DNA repair (by DNA polymerases X family and others)Genetic information transferGene expression regulation
04

Disease associations

CancerInfection (many antivirals and antibiotics target polymerases)Genetic disorders (mutations in polymerase genes cause syndromes and genome instability)Neurological disorders (through effects on DNA repair/transcription)Other (mitochondrial disorders, developmental syndromes)
05

Safety considerations

Off-target toxicity, especially affecting healthy dividing cells (myelosuppression by nucleoside analogs)Mitochondrial toxicity (nucleoside analogs can affect mitochondrial DNA polymerase gamma)Mutagenesis/genomic instability (impaired polymerase fidelity)Resistance development (especially in infectious diseases)
06

Interacting drugs

Nucleoside/tide analogs: azidothymidine, acyclovir, remdesivir (antiviral, for both polymerases in viruses)

4 more in the full profile.

07

Biomarkers

Mutations in POL genes (e.g., POLB, POLG, POLR2A, etc.)Expression levels of specific polymerases (e.g., high POLR2A or POLA1 in cancers)Drug resistance mutations (e.g., HIV-1 RT mutations, rifampicin resistance in mycobacteria)Microsatellite instability for DNA polymerase proofreading deficiency

Beyond the preview

Go deeper on DNA polymerase and RNA polymerase (No universal single abbreviation; commonly as "DNAP" (for DNA polymerase) and "RNAP" (for RNA polymerase) in the literature.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA polymerase and RNA polymerase (No universal single abbreviation; commonly as "DNAP" (for DNA polymerase) and "RNAP" (for RNA polymerase) in the literature.).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call